BrightWater Medical, Inc.

Release Summary

The FDA has cleared BrightWater’s ConvertX™ Nephroureteral Stent System, enabling interventional radiologists to eliminate a second invasive procedure in treating ureteral obstructions.

BrightWater Medical, Inc.